The sense of stopping migraine prophylaxis

The sense of stopping migraine prophylaxis

Abstract Introduction Migraine prophylactic therapy has changed over recent years with the development and approval of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway. As new therapies emerged, leading headache societies have been providing guidelines on the...

Full description

Bibliographic Details
Main Authors: Linda Al-Hassany, Hannah S. Lyons, Deirdre M. Boucherie, Fatemeh Farham, Kristin S. Lange, Karol Marschollek, Dilara Onan, Umberto Pensato, Elisabeth Storch, Angelo Torrente, Marta Waliszewska-Prosół, Uwe Reuter, on behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)
Format: Article
Language:English
Published: BMC 2023-02-01
Series:The Journal of Headache and Pain
Subjects:
Migraine
Preventive treatment
Prophylaxis
Stopping rules
Online Access:https://doi.org/10.1186/s10194-023-01539-8

Internet

https://doi.org/10.1186/s10194-023-01539-8

Similar Items